UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: November 14, 2025
Accession Number: 0001829126-25-007997
Submission Type: POS AM
CIK: 0000910267
Company Name: TITAN PHARMACEUTICALS INC
File Number: 333-230742